US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist
  • 0.6116
  • +0.0416+7.30%
Close Dec 20 16:00 ET
  • 0.5155
  • -0.0961-15.71%
Post 20:01 ET
114.30MMarket Cap-0.01P/E (TTM)

Tonix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.60%-18.8M
57.55%-9.92M
46.60%-17.58M
-4.03%-102M
-0.17%-22.34M
0.64%-23.39M
-10.37%-23.37M
-6.01%-32.91M
-29.77%-98.05M
0.64%-22.3M
Net income from continuing operations
49.19%-14.21M
-177.81%-78.78M
54.74%-14.94M
-5.84%-116.66M
13.76%-27.32M
3.47%-27.98M
-22.54%-28.36M
-24.94%-33.01M
-19.43%-110.22M
-7.20%-31.68M
Operating gains losses
--0
--855K
---7.01M
--221K
--417K
----
----
----
----
----
Depreciation and amortization
-58.06%510K
30.84%1.21M
35.50%1.21M
242.46%4.29M
50.84%1.26M
382.54%1.22M
802.94%921K
1,317.46%893K
2,406.00%1.25M
2,996.30%836K
Other non cash items
--209K
--129K
--302K
--903K
----
----
----
----
----
----
Change In working capital
-544.33%-6.63M
182.81%4.82M
132.42%1.17M
-1,650.00%-35K
-93.77%363K
-38.62%1.49M
280.13%1.7M
50.86%-3.59M
-100.03%-2K
21.78%5.83M
-Change in receivables
-5.19%-1.64M
----
----
----
----
---1.56M
----
----
----
----
-Change in inventory
--1.25M
--1.16M
--1.29M
--61K
--61K
--0
--0
--0
--0
----
-Change in prepaid assets
-111.12%-341K
60.52%2.37M
-12.35%-1.36M
1,059.15%1.57M
-398.98%-1.76M
-15.49%3.07M
166.55%1.47M
44.32%-1.21M
-131.66%-164K
-66.05%589K
-Change in payables and accrued expense
-19,506.67%-5.88M
2,028.44%4.64M
151.64%1.23M
-1,165.00%-1.7M
-90.65%490K
97.50%-30K
-82.78%218K
53.70%-2.38M
-96.97%160K
71.78%5.24M
-Change in other current liabilities
----
----
----
1,650.00%35K
----
----
----
----
--2K
---3K
-Change in other working capital
-135.29%-6K
-133.33%-4K
140.00%2K
----
----
--17K
300.00%12K
-400.00%-5K
----
----
Cash from discontinued investing activities
Operating cash flow
19.60%-18.8M
57.55%-9.92M
46.60%-17.58M
-4.03%-102M
-0.17%-22.34M
0.64%-23.39M
-10.37%-23.37M
-6.01%-32.91M
-29.77%-98.05M
0.64%-22.3M
Investing cash flow
Cash flow from continuing investing activities
98.90%-9K
0
97.16%-108K
39.62%-29.07M
90.77%-431K
90.69%-821K
-66.35%-24.02M
81.21%-3.8M
-36.37%-48.15M
81.77%-4.67M
Net PPE purchase and sale
98.90%-9K
--0
97.16%-108K
85.68%-6.9M
90.77%-431K
90.69%-821K
87.22%-1.85M
81.21%-3.8M
-36.37%-48.15M
81.77%-4.67M
Net business purchase and sale
--0
----
----
---22.17M
--0
--0
----
----
--0
--0
Cash from discontinued investing activities
Investing cash flow
98.90%-9K
--0
97.16%-108K
39.62%-29.07M
90.77%-431K
90.69%-821K
-66.35%-24.02M
81.21%-3.8M
-36.37%-48.15M
81.77%-4.67M
Financing cash flow
Cash flow from continuing financing activities
583.85%42.91M
582.70%7.03M
98.16%-212K
-58.43%36.52M
463.20%40.71M
235.65%6.27M
-98.57%1.03M
-188.03%-11.5M
-58.66%87.84M
-83.48%7.23M
Net issuance payments of debt
---705K
---705K
---235K
--8.94M
--8.94M
--0
--0
--0
--0
----
Net common stock issuance
595.03%43.61M
942.76%10.73M
--0
-94.73%4.97M
-4.49%9.2M
-76.65%6.27M
-97.71%1.03M
-188.53%-11.53M
-55.52%94.46M
-77.99%9.63M
Net preferred stock issuance
----
----
----
--0
----
----
----
----
---6.66M
---2.4M
Proceeds from stock option exercised by employees
--4K
--0
-20.69%23K
-27.50%29K
--0
--0
--0
-27.50%29K
-59.18%40K
--0
Net other financing activities
--0
----
----
--22.57M
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
583.85%42.91M
582.70%7.03M
98.16%-212K
-58.43%36.52M
463.20%40.71M
235.65%6.27M
-98.57%1.03M
-188.03%-11.5M
-58.66%87.84M
-83.48%7.23M
Net cash flow
Beginning cash position
-80.44%5.06M
-88.99%7.95M
-78.54%25.85M
-32.66%120.47M
-94.35%7.92M
-85.41%25.86M
-48.66%72.22M
-32.66%120.47M
131.41%178.9M
-23.47%140.22M
Current changes in cash
234.37%24.1M
93.76%-2.89M
62.88%-17.9M
-62.03%-94.56M
190.88%17.94M
51.51%-17.93M
-226.77%-46.36M
-26.20%-48.21M
-157.42%-58.36M
-359.14%-19.74M
Effect of exchange rate changes
-41.67%-17K
--1K
90.70%-4K
12.16%-65K
-100.00%-10K
40.00%-12K
--0
-72.00%-43K
-138.71%-74K
50.00%-5K
End cash Position
268.06%29.14M
-80.44%5.06M
-88.99%7.95M
-78.54%25.85M
-78.54%25.85M
-94.35%7.92M
-85.41%25.86M
-48.66%72.22M
-32.66%120.47M
-32.66%120.47M
Free cash flow
25.35%-18.81M
60.66%-9.92M
51.83%-17.68M
24.83%-109.9M
15.55%-22.78M
22.12%-25.2M
29.20%-25.21M
28.39%-36.71M
-31.87%-146.2M
43.89%-26.97M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.60%-18.8M57.55%-9.92M46.60%-17.58M-4.03%-102M-0.17%-22.34M0.64%-23.39M-10.37%-23.37M-6.01%-32.91M-29.77%-98.05M0.64%-22.3M
Net income from continuing operations 49.19%-14.21M-177.81%-78.78M54.74%-14.94M-5.84%-116.66M13.76%-27.32M3.47%-27.98M-22.54%-28.36M-24.94%-33.01M-19.43%-110.22M-7.20%-31.68M
Operating gains losses --0--855K---7.01M--221K--417K--------------------
Depreciation and amortization -58.06%510K30.84%1.21M35.50%1.21M242.46%4.29M50.84%1.26M382.54%1.22M802.94%921K1,317.46%893K2,406.00%1.25M2,996.30%836K
Other non cash items --209K--129K--302K--903K------------------------
Change In working capital -544.33%-6.63M182.81%4.82M132.42%1.17M-1,650.00%-35K-93.77%363K-38.62%1.49M280.13%1.7M50.86%-3.59M-100.03%-2K21.78%5.83M
-Change in receivables -5.19%-1.64M-------------------1.56M----------------
-Change in inventory --1.25M--1.16M--1.29M--61K--61K--0--0--0--0----
-Change in prepaid assets -111.12%-341K60.52%2.37M-12.35%-1.36M1,059.15%1.57M-398.98%-1.76M-15.49%3.07M166.55%1.47M44.32%-1.21M-131.66%-164K-66.05%589K
-Change in payables and accrued expense -19,506.67%-5.88M2,028.44%4.64M151.64%1.23M-1,165.00%-1.7M-90.65%490K97.50%-30K-82.78%218K53.70%-2.38M-96.97%160K71.78%5.24M
-Change in other current liabilities ------------1,650.00%35K------------------2K---3K
-Change in other working capital -135.29%-6K-133.33%-4K140.00%2K----------17K300.00%12K-400.00%-5K--------
Cash from discontinued investing activities
Operating cash flow 19.60%-18.8M57.55%-9.92M46.60%-17.58M-4.03%-102M-0.17%-22.34M0.64%-23.39M-10.37%-23.37M-6.01%-32.91M-29.77%-98.05M0.64%-22.3M
Investing cash flow
Cash flow from continuing investing activities 98.90%-9K097.16%-108K39.62%-29.07M90.77%-431K90.69%-821K-66.35%-24.02M81.21%-3.8M-36.37%-48.15M81.77%-4.67M
Net PPE purchase and sale 98.90%-9K--097.16%-108K85.68%-6.9M90.77%-431K90.69%-821K87.22%-1.85M81.21%-3.8M-36.37%-48.15M81.77%-4.67M
Net business purchase and sale --0-----------22.17M--0--0----------0--0
Cash from discontinued investing activities
Investing cash flow 98.90%-9K--097.16%-108K39.62%-29.07M90.77%-431K90.69%-821K-66.35%-24.02M81.21%-3.8M-36.37%-48.15M81.77%-4.67M
Financing cash flow
Cash flow from continuing financing activities 583.85%42.91M582.70%7.03M98.16%-212K-58.43%36.52M463.20%40.71M235.65%6.27M-98.57%1.03M-188.03%-11.5M-58.66%87.84M-83.48%7.23M
Net issuance payments of debt ---705K---705K---235K--8.94M--8.94M--0--0--0--0----
Net common stock issuance 595.03%43.61M942.76%10.73M--0-94.73%4.97M-4.49%9.2M-76.65%6.27M-97.71%1.03M-188.53%-11.53M-55.52%94.46M-77.99%9.63M
Net preferred stock issuance --------------0-------------------6.66M---2.4M
Proceeds from stock option exercised by employees --4K--0-20.69%23K-27.50%29K--0--0--0-27.50%29K-59.18%40K--0
Net other financing activities --0----------22.57M------------------------
Cash from discontinued financing activities
Financing cash flow 583.85%42.91M582.70%7.03M98.16%-212K-58.43%36.52M463.20%40.71M235.65%6.27M-98.57%1.03M-188.03%-11.5M-58.66%87.84M-83.48%7.23M
Net cash flow
Beginning cash position -80.44%5.06M-88.99%7.95M-78.54%25.85M-32.66%120.47M-94.35%7.92M-85.41%25.86M-48.66%72.22M-32.66%120.47M131.41%178.9M-23.47%140.22M
Current changes in cash 234.37%24.1M93.76%-2.89M62.88%-17.9M-62.03%-94.56M190.88%17.94M51.51%-17.93M-226.77%-46.36M-26.20%-48.21M-157.42%-58.36M-359.14%-19.74M
Effect of exchange rate changes -41.67%-17K--1K90.70%-4K12.16%-65K-100.00%-10K40.00%-12K--0-72.00%-43K-138.71%-74K50.00%-5K
End cash Position 268.06%29.14M-80.44%5.06M-88.99%7.95M-78.54%25.85M-78.54%25.85M-94.35%7.92M-85.41%25.86M-48.66%72.22M-32.66%120.47M-32.66%120.47M
Free cash flow 25.35%-18.81M60.66%-9.92M51.83%-17.68M24.83%-109.9M15.55%-22.78M22.12%-25.2M29.20%-25.21M28.39%-36.71M-31.87%-146.2M43.89%-26.97M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List

Investment Theme Mpox (monkeypox)
Mpox (monkeypox)
Intraday+1.25%